Tiago Marques Pasithea Therapeutics Corp. (KTTA) insider trading activity

KTTA Quotes by TradingView

Tiago Marques is Chief Executive Officer of Pasithea Therapeutics Corp.. Currently has a direct ownership of 40,001 shares of KTTA, which is worth approximately $27,600. The most recent transaction as insider was on May 12, 2025, when has been sold 960 shares (Common Stock) at a price of $0.82 per share, resulting in proceeds of $787. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 40K
95.12% 3M change
95.12% 12M change
Total Value Held $27,600

Tiago Marques Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 12 2025
SELL
Open market or private sale
$787 $0.82 p/Share
960 Reduced 2.34%
40,001 Common Stock
Nov 25 2022
BUY
Grant, award, or other acquisition
$2,060 $1.03 p/Share
2,000 Added 0.24%
819,206 Common Stock
Nov 23 2022
BUY
Grant, award, or other acquisition
$7,350 $1.02 p/Share
7,206 Added 0.87%
817,206 Common Stock
Oct 21 2022
BUY
Grant, award, or other acquisition
$5,400 $1.08 p/Share
5,000 Added 0.61%
810,000 Common Stock
Jun 23 2022
BUY
Grant, award, or other acquisition
$4,950 $0.99 p/Share
5,000 Added 0.62%
805,000 Common Stock
Dec 20 2021
BUY
Grant, award, or other acquisition
-
200,000 Added 20.0%
800,000 Common Stock
TM

Tiago Marques

Chief Executive Officer
Miami Beach, FL

Track Institutional and Insider Activities on KTTA

Follow Pasithea Therapeutics Corp. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KTTA shares.

Notify only if

Insider Trading

Get notified when an Pasithea Therapeutics Corp. insider buys or sells KTTA shares.

Notify only if

News

Receive news related to Pasithea Therapeutics Corp.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KTTA